These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24958344)

  • 21. Heparin sodium compliance to USP monograph: structural elucidation of an atypical 2.18 ppm NMR signal.
    Mourier PA; Guichard OY; Herman F; Viskov C
    J Pharm Biomed Anal; 2012; 67-68():169-74. PubMed ID: 22579602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass spectrometric methods for the analysis of heparin and heparan sulfate.
    Lech M; Capila I; Kaundinya GV
    Methods Mol Biol; 2015; 1229():119-28. PubMed ID: 25325949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular weight measurements of low molecular weight heparins by gel permeation chromatography.
    Mulloy B; Gee C; Wheeler SF; Wait R; Gray E; Barrowcliffe TW
    Thromb Haemost; 1997 Apr; 77(4):668-74. PubMed ID: 9134640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Examination of the heterogeneity of heparin. IV. Crude heparin].
    Jarzebiński J; Gryz K; Tońska S
    Acta Pol Pharm; 1993; 50(2-3):127-9. PubMed ID: 8030421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin sodium compliance to the new proposed USP monograph: elucidation of a minor structural modification responsible for a process dependent 2.10 ppm NMR signal.
    Mourier PA; Guichard OY; Herman F; Viskov C
    J Pharm Biomed Anal; 2011 Jan; 54(2):337-44. PubMed ID: 20934294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of crude heparin and commercial preparation of Polish production].
    Jarzebiński J; Tońska S; Remiszewska H
    Acta Pol Pharm; 1989; 46(2):179-82. PubMed ID: 2561044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Heparin Sodium Reference Standard (Control 991) of National Institute of Health Sciences].
    Saito H; Iwata M; Maekawa K; Tanimoto T; Okada S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2000; (118):154-5. PubMed ID: 11534120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular sizes of enzyme-bound immunoglobulins].
    Nakayama T
    Rinsho Byori; 1984 Nov; Spec No 60():59-67. PubMed ID: 6530770
    [No Abstract]   [Full Text] [Related]  

  • 29. Relative activities of heparin fractions obtained by gel chromatography.
    Graham DT; Pomeroy AR
    Thromb Haemost; 1980 Feb; 42(5):1598-603. PubMed ID: 7368160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the USP heparin monograph and implications for clinicians.
    Smythe MA; Nutescu EA; Wittkowsky AK
    Pharmacotherapy; 2010 May; 30(5):428-31. PubMed ID: 20411994
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening of heparin API by near infrared reflectance and Raman spectroscopy.
    Spencer JA; Kauffman JF; Reepmeyer JC; Gryniewicz CM; Ye W; Toler DY; Buhse LF; Westenberger BJ
    J Pharm Sci; 2009 Oct; 98(10):3540-7. PubMed ID: 19117047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gel filtration behavior of heparin and N-desulfated heparin.
    Sumyk GB; Yocum CF
    J Chromatogr; 1968 May; 35(1):101-3. PubMed ID: 5656412
    [No Abstract]   [Full Text] [Related]  

  • 33. Size-exclusion chromatography of heparin oligosaccharides at high and low pressure.
    Ziegler A; Zaia J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):76-86. PubMed ID: 16704936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of glycosaminoglycans and proteoglycans.
    Rider CC
    Methods Mol Biol; 1998; 76():131-43. PubMed ID: 9664351
    [No Abstract]   [Full Text] [Related]  

  • 35. Sodium heparin determination: comparison of an instrumental method with the USP method.
    Reed M; Wilson G; Davenport W; Schmitz T; Klamrzynski M
    J Pharm Sci; 1974 Sep; 63(9):1455-7. PubMed ID: 4427272
    [No Abstract]   [Full Text] [Related]  

  • 36. De facto molecular weight distributions of glucans by size-exclusion chromatography combined with mass/molar-detection of fluorescence labeled terminal hemiacetals.
    Praznik W; Huber A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):295-307. PubMed ID: 16112622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case study: contamination of heparin with oversulfated chondroitin sulfate.
    Chess EK; Bairstow S; Donovan S; Havel K; Hu P; Johnson RJ; Lee S; McKee J; Miller R; Moore E; Nordhaus M; Ray J; Szabo C; Wielgos T
    Handb Exp Pharmacol; 2012; (207):99-125. PubMed ID: 22566223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of tea glycoprotein and its application as a calibration standard for the quantification and molecular weight determination of tea glycoprotein in different tea samples by high-performance gel-permeation chromatography.
    Nie S; Xie M; Wang Y
    Anal Bioanal Chem; 2005 Oct; 383(4):680-6. PubMed ID: 16184368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biological and HPLC analysis of heparin after thermal treatment].
    Pintabona A; Bottazzi A; Capra R
    Boll Chim Farm; 1991 Dec; 130(11):439-42. PubMed ID: 1809297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gel chromatography and analytical ultracentrifugation to determine the extent of detergent binding and aggregation, and Stokes radius of membrane proteins using sarcoplasmic reticulum Ca2+-ATPase as an example.
    le Maire M; Arnou B; Olesen C; Georgin D; Ebel C; Møller JV
    Nat Protoc; 2008; 3(11):1782-95. PubMed ID: 18974737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.